You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 21, 2026

VENLAFAXINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Venlafaxine patents expire, and what generic alternatives are available?

Venlafaxine is a drug marketed by Almatica, Alembic, Anchen Pharms, Annora Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Inventia Hlthcare, Macleods Pharms Ltd, Medicap Labs, Nostrum Pharms Llc, Orbion Pharms, Pharmobedient, Sciegen Pharms, Teva, Torrent, Valeant Pharms North, Yichang Humanwell, Zydus Pharms Usa Inc, Abon Pharms Llc, Adaptis, Ajanta Pharma Ltd, Alkem Labs Ltd, Ascent Pharms Inc, Cadila Pharms Ltd, Dexcel, Mpp Pharma, Osmotica Pharm Us, Somerset Theraps Llc, Sun Pharm, Swiss Pharm, Unique, Zydus Pharms, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Chartwell Rx, Heritage, Pliva Hrvatska Doo, Prinston Inc, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa. and is included in forty-eight NDAs. There is one patent protecting this drug.

The generic ingredient in VENLAFAXINE is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VENLAFAXINE?
  • What are the global sales for VENLAFAXINE?
  • What is Average Wholesale Price for VENLAFAXINE?
Summary for VENLAFAXINE
US Patents:0
Applicants:43
NDAs:48
Drug Prices: Drug price information for VENLAFAXINE
Drug Sales Revenues: Drug sales revenues for VENLAFAXINE
What excipients (inactive ingredients) are in VENLAFAXINE?VENLAFAXINE excipients list
DailyMed Link:VENLAFAXINE at DailyMed
Drug patent expirations by year for VENLAFAXINE
Drug Prices for VENLAFAXINE

See drug prices for VENLAFAXINE

Drug Sales Revenue Trends for VENLAFAXINE

See drug sales revenues for VENLAFAXINE

US Patents and Regulatory Information for VENLAFAXINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cadila Pharms Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 211323-002 Aug 29, 2019 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Zydus Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 215622-004 Aug 30, 2022 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Teva VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076565-001 Jun 28, 2010 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Orbion Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 091123-001 Jul 11, 2011 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Zydus Pharms Usa VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 077653-002 Jun 13, 2008 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Teva VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 076690-002 Aug 3, 2006 AB RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.